A Game-changer in Non-invasive Diagnostics
Breakthrough AI Driven Sensing Technology for Disease Screening and Management at Early Stage Using Breath Biomarkers
The importance
of early detection
Currently, in spite of the technological progress made in various fields, 50% of chronic diseases and cancers are diagnosed at a late stage, when treatment efficacy is low. Prevention or early diagnosis through innovative technologies can mitigate the suffering caused by late-stage disease diagnoses.
Early diagnosis is pivotal in effectively managing and treating diseases before they escalate into more severe conditions like cancer. Additionally, effective patient management and timely treatment can dramatically improve outcomes and save lives when illness is unavoidable.
The Dianose
This has led us to develop a different approach to sensing technology. We have developed a remote condition management device based on cutting-edge technology using Nano technology and machine learning to achieve this vision of a healthier future for all. With Dianose, we offer a vital, user-friendly tool so that patients and healthcare professionals alike can take early action and implement intensive monitoring and care. This will result in lives saved and reduced suffering.
We are committed to continuing to push the boundaries of technology to make healthcare more accessible and effective for everyone.
In 2024, NaNose Medical received a significant grant from the EU-EIC to support its ReLiV project.
Our Technology
Nanose Medical – Power of Nanotechnology & Artificial Intelligence –
As Easy As Breathing !
Noninvasive
Portable handheld device
Rapid results
Simple - reduces user skill dependency
Portable handheld device
Rapid results
Noninvasive
Simple - reduces user skill dependency
Affordable
High accuracy
Affordable
High accuracy
Nanose Medical - fighting lung cancer
Nanose Medical is taking part in LUCIA an international project and consortium supported by the Horizon Europe Program with the mission of improving early detection and management of lung cancer
